News

Fujifilm Biotechnologies is preparing to open the first phase of its massive biologics manufacturing campus in Holly Springs, North Carolina, a site designed to rank among ...
Kodiak Sciences' pipeline, led by tarcocimab, targets less frequent dosing for retinal diseases but faces tough competition ...
These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...
Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...
Regeneron Pharmaceuticals faced a setback as the FDA postponed its decision on EYLEA HD's approvals to late 2025. This delay ...
J&J said on Thursday it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Biotechnologies for ...
A hedge fund run by legendary investor Michael Burry kicked off a new $383 million bullish bet split between four different ...
The company will be heavily investing over the next decade to build a new biopharmaceutical facility in Holly Springs, NC, ...